---
aliases: [PFE]
---
#actor #healthcare #pharma #usa #public

**Pfizer** — Large-cap pharma. COVID vaccine success, now navigating patent cliff. AI investments in R&D.

---

## Why Pfizer matters

| Metric | Value |
|--------|-------|
| Market cap | ~$150B |
| Ticker | PFE (NYSE) |
| Focus | Vaccines, oncology, rare disease |
| Challenge | Post-COVID revenue normalization |

---

## AI initiatives

| Area | Application |
|------|-------------|
| Drug discovery | ML for target identification |
| Clinical trials | AI patient matching |
| Manufacturing | Process optimization |

---

## Investment case

**Bull:**
- Pipeline optionality
- Dividend yield (~6%)
- M&A capacity
- COVID learnings applicable

**Bear:**
- Patent cliff pressure
- COVID revenue collapsed
- GLP-1 late entrant
- Pipeline execution risk

---

## Related

- [[Eli Lilly]] — pharma peer
- [[Moderna]] — vaccine competitor
